Suppr超能文献

人类血小板拥有一种淋巴因子的受体:人γ干扰素高特异性受体的证实。

Human platelets possess receptors for a lymphokine: demonstration of high specific receptors for HuIFN-gamma.

作者信息

Molinas F C, Wietzerbin J, Falcoff E

出版信息

J Immunol. 1987 Feb 1;138(3):802-6.

PMID:2949008
Abstract

This report demonstrates that 125I-recombinant human interferon-gamma (125I-rHuIFN-gamma) binds to high-affinity specific receptors on human platelets. Scatchard analysis of binding data indicates the presence of homogeneous sites estimated in the order of 150 to 200, with an apparent equilibrium dissociation constant, Kd, of 2 X 10(-10) M. The binding of 125I-rHuIFN-gamma to platelet membrane was inhibited by unlabeled rHuIFN-gamma but not by unlabeled rHuIFN-alpha or unlabeled rHuIFN-beta. High affinity binding sites for HuIFN-alpha were not detectable. Cross-linking of 125I-rHuIFN-gamma to platelet membrane proteins with the use of a bifunctional agent (DSS) yielded a predominant complex of 100,000 +/- 5,000 daltons on SDS-PAGE autoradiography, which confirms the presence of specific receptors for IFN-gamma. Two faint bands of lower m.w., 70,000 and 90,000, could also be visualized. Cross-linking of 125I-rHuIFN-alpha to platelet surface could not be demonstrated by using the same procedures. This is the first time that a receptor for a lymphokine (IFN-gamma) has been demonstrated on human platelets. These findings are consistent with data already published, suggesting an interrelationship between IFN and platelet function.

摘要

本报告表明,125I重组人干扰素-γ(125I-rHuIFN-γ)可与人血小板上的高亲和力特异性受体结合。对结合数据进行Scatchard分析表明,存在约150至200个同质位点,其表观平衡解离常数Kd为2×10(-10)M。未标记的rHuIFN-γ可抑制125I-rHuIFN-γ与血小板膜的结合,但未标记的rHuIFN-α或rHuIFN-β则无此作用。未检测到HuIFN-α的高亲和力结合位点。使用双功能试剂(DSS)将125I-rHuIFN-γ与血小板膜蛋白交联,在SDS-PAGE放射自显影上产生了一个主要的100,000±5,000道尔顿的复合物,这证实了IFN-γ特异性受体的存在。还可看到两条较低分子量的模糊条带,分别为70,000和90,000。使用相同程序未能证明125I-rHuIFN-α与血小板表面的交联。这是首次在人血小板上证明淋巴因子(IFN-γ)的受体。这些发现与已发表的数据一致,提示IFN与血小板功能之间存在相互关系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验